Carolina Terragna

3.9k total citations
99 papers, 2.3k citations indexed

About

Carolina Terragna is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Carolina Terragna has authored 99 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Hematology, 45 papers in Molecular Biology and 30 papers in Oncology. Recurrent topics in Carolina Terragna's work include Multiple Myeloma Research and Treatments (51 papers), Chronic Myeloid Leukemia Treatments (29 papers) and Protein Degradation and Inhibitors (25 papers). Carolina Terragna is often cited by papers focused on Multiple Myeloma Research and Treatments (51 papers), Chronic Myeloid Leukemia Treatments (29 papers) and Protein Degradation and Inhibitors (25 papers). Carolina Terragna collaborates with scholars based in Italy, United States and Greece. Carolina Terragna's co-authors include Michèle Cavo, Elena Zamagni, S Tura, Michele Baccarani, Giovanni Martinelli, Paola Tacchetti, Nicoletta Testoni, Patrizia Tosi, Giulia Perrone and Annamaria Brioli and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Carolina Terragna

96 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carolina Terragna Italy	25	1.8k	1.2k	885	354	311	99	2.3k
Éric Jourdan France	18	1.3k 0.7×	733 0.6×	570 0.6×	407 1.1×	568 1.8×	54	2.1k
María Teresa Cibeira Spain	23	1.3k 0.7×	1.3k 1.1×	709 0.8×	398 1.1×	182 0.6×	91	2.0k
Todd M. Zimmerman United States	28	1.6k 0.9×	1.2k 1.0×	990 1.1×	219 0.6×	313 1.0×	95	2.2k
Toshiko Motoji Japan	26	1.5k 0.9×	915 0.8×	578 0.7×	700 2.0×	399 1.3×	121	2.6k
Álvaro Aguayo Mexico	19	867 0.5×	933 0.8×	506 0.6×	501 1.4×	148 0.5×	46	1.8k
Shinichi Mizuno Japan	16	698 0.4×	1.0k 0.9×	405 0.5×	210 0.6×	316 1.0×	46	1.8k
Christine Arnoulet France	28	1.6k 0.9×	885 0.7×	624 0.7×	702 2.0×	809 2.6×	69	2.6k
K.R. Desikan United States	18	1.6k 0.9×	997 0.8×	787 0.9×	245 0.7×	176 0.6×	31	1.9k
Leonard T. Heffner United States	21	996 0.6×	856 0.7×	784 0.9×	561 1.6×	227 0.7×	86	1.8k
Hélène A. Poirel Belgium	23	778 0.4×	804 0.7×	674 0.8×	637 1.8×	351 1.1×	56	2.1k

Countries citing papers authored by Carolina Terragna

Since Specialization

Citations

This map shows the geographic impact of Carolina Terragna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolina Terragna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolina Terragna more than expected).

Fields of papers citing papers by Carolina Terragna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolina Terragna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolina Terragna. The network helps show where Carolina Terragna may publish in the future.

Co-authorship network of co-authors of Carolina Terragna

This figure shows the co-authorship network connecting the top 25 collaborators of Carolina Terragna. A scholar is included among the top collaborators of Carolina Terragna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolina Terragna. Carolina Terragna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borsi, Enrica, Marina Martello, Elena Zamagni, et al.. (2023). High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients. Clinical and Experimental Medicine. 23(8). 5227–5239. 4 indexed citations

Sabattini, Elena, Alessandro Broccoli, Claudio Agostinelli, et al.. (2022). Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(5). 899–904.

Broccoli, Alessandro, Lisa Argnani, Carolina Terragna, et al.. (2021). The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30‐year experience. American Journal of Hematology. 96(10). 1204–1210. 8 indexed citations

Ziccheddu, Bachisio, Giulia Biancon, Chiara De Philippis, et al.. (2020). Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma. Blood Advances. 4(5). 830–844. 49 indexed citations

Forte, Dorian, Flaminia Fanelli, Marco Mezzullo, et al.. (2020). Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms. International Journal of Molecular Sciences. 21(9). 3399–3399. 5 indexed citations

Rorà, Andrea Ghelli Luserna di, Anna Ferrari, Carolina Terragna, et al.. (2019). Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia. Cancers. 11(11). 1654–1654. 22 indexed citations

Zamagni, Elena, et al.. (2016). Multiple myeloma: disease response assessment. Expert Review of Hematology. 9(9). 831–837. 7 indexed citations

Zamagni, Elena, Cristina Nanni, Katia Mancuso, et al.. (2015). PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma. Clinical Cancer Research. 21(19). 4384–4390. 107 indexed citations

Zamagni, Elena, Cristina Nanni, Paola Tacchetti, et al.. (2014). Positron Emission Tomography With Computed Tomography–Based Diagnosis of Massive Extramedullary Progression in a Patient With High-Risk Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 14(3). e101–e104. 7 indexed citations

10.

Bringhen, Sara, Lucia Pantani, Annalisa Pezzi, et al.. (2013). Superior Outcomes With Bortezomib Or Thalidomide Incorporated Into Autologous Stem Cell Transplantation (ASCT) Versus Novel Agent-Based Treatments For Elderly Patients With Newly Diagnosed Multiple Myeloma (MM): A Case-Match Comparison. Blood. 122(21). 3344–3344. 1 indexed citations

11.

Porro, Antônio, Nunzio Iraci, Simona Soverini, et al.. (2011). c-MYC Oncoprotein Dictates Transcriptional Profiles of ATP-Binding Cassette Transporter Genes in Chronic Myelogenous Leukemia CD34+ Hematopoietic Progenitor Cells. Molecular Cancer Research. 9(8). 1054–1066. 38 indexed citations

12.

Terragna, Carolina, Marina Martello, Sandra Durante, et al.. (2011). High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53,. Blood. 118(21). 3935–3935. 1 indexed citations

13.

Martinelli, Giovanni, Ilaria Iacobucci, Daniela Cilloni, et al.. (2009). New drugs to overcome meccanisms of resistance in Ph+ leukemia: bosutinib. 2(5). 27–32. 1 indexed citations

14.

Soverini, Simona, Sabrina Colarossi, Alessandra Gnani, et al.. (2009). High-Resolution Genome Wide Copy Number Alteration (CNA) and Loss of Heterozigosity (LOH) Analysis in Chronic Myeloid Leukemia (CML) Shows That High and Intermediate Sokal Risk Pts (Pts) Have Multiple Losses Targeting Genes Involved in DNA Repair.. Blood. 114(22). 3262–3262. 2 indexed citations

15.

Cavo, Michèle, Elena Zamagni, Paola Tacchetti, et al.. (2009). Single or Double Autologous Stem Cell Transplantation Before and After the Era of Novel Agents. Clinical Lymphoma & Myeloma. 9. S51–S52.

16.

Re, Francesca, Mario Arpinati, Nicoletta Testoni, et al.. (2002). Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage. Experimental Hematology. 30(2). 126–134. 41 indexed citations

17.

Amabile, Marilina, Barbara Giannini, Nicoletta Testoni, et al.. (2001). Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.. PubMed. 86(3). 252–9. 36 indexed citations

18.

Giannini, Barbara, Vittorio Montefusco, Nicoletta Testoni, et al.. (2000). Real-time quantification of different types of BcrAbl transcript in chronic myeloid leukemia. Blood. 96. 16 indexed citations

19.

Martinelli, Giovanni, Carolina Terragna, Marilina Amabile, et al.. (2000). Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.. PubMed. 85(1). 40–6. 21 indexed citations

20.

Ratta, Marina, Damiano Rondelli, Alessandra Fortuna, et al.. (1998). Generation and functional characterization of human dendritic cells derived from CD34⁺ cells mobilized into peripheral blood: comparison with bone marrow CD34⁺ cells. British Journal of Haematology. 101(4). 756–765. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact